Quarterly Results

  • Company Name :
Lupin Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 500257
  • NSE Symbol:
  • LUPIN
  • P/E(TTM):
  • 19.02
  • ISIN Demat:
  • INE326A01037
  • Div & Yield%:
  • 0.52
  • EPS(TTM):
  • 120.99
  • Book Value(₹):
  • 595.67
  • Market Cap(₹Cr.):
  • 105,181.64
  • Face Value(₹):
  • 2.00
Quarters :  
Particulars December 2025 ( Cr)September 2025 ( Cr)June 2025 ( Cr)
Gross Sales 4,433.96 3,852.79 5,605.41
Excise Duty 0.00 0.00 0.00
Net Sales 4,433.96 3,852.79 5,605.41
Other Operating Income 67.23 215.49 103.18
Other Income 99.80 662.68 54.14
Total Income 4,600.99 4,730.96 5,762.73
Total Expenditure 3,518.35 2,892.65 2,978.95
PBIDT 1,082.64 1,838.31 2,783.78
Interest 36.02 27.78 18.90
PBDT 1,046.62 1,810.53 2,764.88
Depreciation 178.68 174.72 176.73
Tax 141.40 287.23 451.54
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 9.09 -8.77 8.54
Reported Profit After Tax 717.45 1,357.35 2,128.07
Extra-ordinary Items -523.94 488.61 0.00
Adjusted Profit After Extra-ordinary item 1,241.39 868.74 2,128.07
EPS (Unit Curr.) 15.71 29.72 46.60
EPS (Adj) (Unit Curr.) 15.71 29.72 46.60
Calculated EPS (Unit Curr.) 15.70 29.71 46.59
Calculated EPS (Adj) (Unit Curr.) 15.70 29.71 46.59
Calculated EPS (Ann.) (Unit Curr.) 62.82 118.86 186.37
Calculated EPS (Adj) (Ann.) (Unit Curr.) 62.82 118.86 186.37
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 91.37 91.36 91.35
Reserve & Surplus 0.00 0.00 0.00
Face Value 2.00 2.00 2.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 24.42 47.71 49.66
PBDTM(%) 23.60 46.99 49.33
PATM(%) 16.18 35.23 37.96